Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 6 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
51 43.9 months Recurrent Ovarian Cancer 5 Chemotherapy
University Medical Center Hamburg-Eppendorf Germany 2/2015
Treatment Details: Patients: This phase 3 study involved platinum-sensitive, recurrent ovarian cancer patients who were divided into two separate treatment groups. Group A had 131 patients with a median age o
 
52 43.9 months Castration-resistant prostate cancer 5 Biologic therapy
Massachusetts General Hospital Cancer Center United States 1/2012
Treatment Details: Patients: This phase 3 study involved 716 men with castration-resistant prostate cancer. The median patient age was 74 years. Treatment: Patients were treated with the biologic therapy
 
53 43.8 months Ovarian cancer 5 Chemotherapy
M.D. Anderson Cancer Center Orlando United States 12/2011
Treatment Details: Patients: This phase III study involved women with ovarian cancer who were divided into two separate treatment groups. Group A consisted of 417 patients with a median age of 60 years. Gro
 
54 43.3 months Metastatic breast cancer 4 Biologic therapy
University Hospital Gasthuisberg Belgium 10/2008
Treatment Details: Patients: This phase 3 study involved 371 women with metastatic breast cancer. All the women in this trial were post-menopausal. The median age was 63, ranging from 37 to 87 years of age.
 
55 43.0 months NHL 5 Chemotherapy
Hormone
Mansoura University Egypt 11/2014
Treatment Details: Patients: This study involved HCV-positive diffuse large B-cell lymphoma patients who were divided into two separate treatment groups. Group A consisted of 200 patients with an average age
 
56 42.4 months Advanced ovarian cancer 4 Chemotherapy
Oslo University Hospital Norway 10/2012
Treatment Details: Patients: This phase 3 study involved previously untreated advanced ovarian cancer patients who were divided into two separate treatment groups. Group A consisted of 445 patients with a me
 
57 42.3 months Ovarian cancer 5 Chemotherapy
Vancouver Clinic Canada 10/2010
Treatment Details: Patients: This phase 3 trial involved women with newly diagnosed ovarian cancer who had not received previous chemotherapy. Patients were divided into two treatment groups. Group 1 consis
 
58 42.1 months Ovarian cancer 5 Chemotherapy
Vancouver Clinic Canada 10/2010
Treatment Details: Patients: This phase 3 trial involved women with newly diagnosed ovarian cancer who had not received previous chemotherapy. Patients were divided into two treatment groups. Group 1 consis
 
59 42.1 months Ovarian Cancer 3 Radiation
University of Heidelberg Germany 3/2015
Treatment Details: Patients: This phase 2 study involved 16 ovarian cancer patients who had received prior carboplatin/taxane chemotherapy. The median patient age was 57 years. Treatment: Patients receiv
 
60 41.5 months Melanoma 4 Immunotherapy
Churchill Hospital United Kingdom 1/2014
Treatment Details: Patients: This phase 2 study involved 96 melanoma patients with a median age of 53 years and 47.9% male. Treatment: Patients received immunotherapy with interferon-alpha 2b (IFN-a-2b),
 
Page 6 of 187  | Previous Page  | Next Page